BlackRock
ANAC

BlackRock’s ANACOR PHARMACEUTICALS INC COM ANAC Stock Holding History

BlackRock’s Portfolio ANAC Stock Details ANAC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q2 		– Sell
-108,241
Closed -$5.79M – 3967
2016
Q1 		$5.79M Buy
108,241
+6,638
+7% +$490K 0.01% 827
2015
Q4 		$11.5M Sell
101,603
-17,081
-14% -$1.88M 0.02% 647
2015
Q3 		$14M Buy
118,684
+82,200
+225% +$10.7M 0.02% 570
2015
Q2 		$2.83M Sell
36,484
-1,605
-4% -$105K ﹤0.01% 1007
2015
Q1 		$2.2M Buy
38,089
+937
+3% +$39.8K ﹤0.01% 1058
2014
Q4 		$1.2M Buy
37,152
+36,360
+4,591% +$1.09M ﹤0.01% 1173
2014
Q3 		$19K Hold
792
– – ﹤0.01% 2385
2014
Q2 		$14K Buy
792
+76
+11% +$1.22K ﹤0.01% 2598
2014
Q1 		$14K Buy
716
+114
+19% +$2.21K ﹤0.01% 2563
2013
Q4 		$10K Hold
602
– – ﹤0.01% 2765
2013
Q3 		$6K Buy
+602
New +$5.27K ﹤0.01% 2978

Other funds holding ANAC

KCM
Kingdon Capital Management New York $911M AUM 51.11% 1-Year Est. Return
CIM
CIM Investment Management Pittsburgh, Pennsylvania $375M AUM 32.03% 1-Year Est. Return

BlackRock's ANAC Position: Q2 2016 in Review

BlackRock sold out of ANACOR PHARMACEUTICALS INC COM (ANAC) in Q2 2016, closing a stake of 108,241 shares — an estimated $5.79M sold.

BlackRock first reported a position in ANAC in Q3 2013 and held it in 11 quarters. The position peaked at $14M in Q3 2015. 2 funds tracked by Wall St. Rank hold ANAC as of Q2 2016.

  • BlackRock reported no remaining ANACOR PHARMACEUTICALS INC COM position as of Q2 2016 after selling out during the quarter.
  • BlackRock sold 108,241 ANACOR PHARMACEUTICALS INC COM shares in Q2 2016, an estimated $5.79M.
  • BlackRock first reported a position in ANACOR PHARMACEUTICALS INC COM in Q3 2013 and held it in 11 quarters.
  • BlackRock's ANACOR PHARMACEUTICALS INC COM position peaked at $14M in Q3 2015.
  • 2 funds tracked by Wall St. Rank held ANACOR PHARMACEUTICALS INC COM as of Q2 2016.

Based on BlackRock's 13F filing for Q2 2016, filed 10 Aug 2016.